Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2024 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
appointed, arm, built, Cabatuan, CAD, chemical, chronic, cleared, comply, composition, compound, conclusion, conventional, crucial, daily, dataset, diabetic, dissolvable, dual, earned, Eli, Employment, extended, formal, GIP, global, glycemic, Importantly, incidence, Inclusion, ingredient, injectable, injection, Insider, insulinotropic, intend, letter, Lilly, liraglutide, long, microbiological, Nelson, paid, partnering, PK, polypeptide, Premier, proceed, pronounced, prosecution, purity, pursuit, rat, responding, run, salcaprozate, satisfaction, SNAC, sodium, source, sugar, tablet, Targeted, tirzepatide, tissue, tolerability, tolerated, trading, undertaken, USD, Wainwright, witnessed, Zepbound
Removed:
accelerated, achieve, approval, approved, candidate, commercialization, confirmatory, continually, coverage, CRO, delay, designating, Docherty, dosed, expanding, highlight, integral, John, Maxim, molecule, obtain, par, past, preparing, promoting, small, Supplemental, timetable, unrealized, voting
Valuein 2023 Q1 filing- Value in 2024 Q2 filing
Original filings
Filing view